The NExT Trial: Testing TMS with Exposure Therapy for Youth with OCD
Author Information
Author(s): Conelea Christine, Breitenfeldt Claire, Wilens Alixandra, Carpenter Linda, Greenberg Benjamin, Herren Jennifer, Jacob Suma, Lewis Charles, McLaughlin Nicole, Mueller Bryon A., Nelson Steve, O’Connor Erin, Righi Giulia, Widge Alik S., Fiecas Mark, Benito Kristen
Primary Institution: University of Minnesota
Hypothesis
Augmenting ERP with rTMS will enhance response prevention and improve treatment outcomes for youth with OCD.
Conclusion
The NExT trial aims to determine if TMS can effectively enhance exposure therapy for youth suffering from OCD.
Supporting Evidence
- ERP is a first-line treatment for OCD but is insufficiently effective for many youth.
- Compulsivity in OCD is linked to imbalances in neural circuits.
- TMS has shown promise in enhancing treatment outcomes for OCD.
Takeaway
This study is trying to see if a special brain treatment can help kids with OCD feel better when they face their fears.
Methodology
A two-phase, multisite randomized controlled trial comparing TMS augmentation of ERP in youth with OCD.
Potential Biases
Potential bias in participant selection and reporting of outcomes.
Limitations
The study may not generalize to all youth with OCD due to specific inclusion/exclusion criteria.
Participant Demographics
Youth aged 12-21 years with OCD.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website